AHF is primarily indicated for patients with congenital Factor VIII deficiency (Hemophilia A) and occasionally for .
Used "on-demand" to stop active bleeding episodes from trauma or injury. antihaemophilic factor
Modern medicine offers two main types of factor replacement: highlights of prescribing information AHF is primarily indicated for patients with congenital
Regularly scheduled infusions (often 3 times per week) to prevent spontaneous bleeding and reduce long-term joint damage. Core Indications & Uses
Administered before and after surgery (perioperative management) to ensure safe clotting during the procedure. Types of AHF Products
Antihaemophilic Factor (AHF), or , is a vital blood-clotting protein used to treat and manage Hemophilia A , a genetic disorder where the body lacks enough of this factor to form clots properly. Without it, even minor injuries can lead to prolonged, dangerous bleeding into joints and internal organs. Core Indications & Uses